data china masterChina drug master file (DMF) policy was implemented by China NMPA (formerly CFDA) in July 2019. Under this policy, it is common for drug product applicants to expect their suppliers toWhile both programs address the function of data analytics, the Master of Data In China alone, the market for b data is experiencing an annual growth of